Comparative analysis of the Vitek 2 antifungal susceptibility system and E-test with the CLSI M27-A3 broth microdilution method for susceptibility testing of Indian clinical isolates of Cryptococcus neoformans. (Q50962922)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 February 2012

Language	Label	Description	Also known as
English	Comparative analysis of the Vitek 2 antifungal susceptibility system and E-test with the CLSI M27-A3 broth microdilution method for susceptibility testing of Indian clinical isolates of Cryptococcus neoformans.	scientific article published on 22 February 2012

Statements

scholarly article

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22354778

Comparative analysis of the Vitek 2 antifungal susceptibility system and E-test with the CLSI M27-A3 broth microdilution method for susceptibility testing of Indian clinical isolates of Cryptococcus neoformans. (English)

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22354778

0 references

Cryptococcus neoforman

1 reference

based on heuristic

inferred from title

author name string

Aarti Tewari

1

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22354778

Bijayani Behera

2

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22354778

Purva Mathur

3

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22354778

Immaculata Xess

4

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22354778

publication date

22 February 2012

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22354778

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22354778

173

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22354778

5-6

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22354778

427-433

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22354778

https://scigraph.springernature.com/pub.10.1007/s11046-012-9528-9

0 references

Cryptococcosis in India: the awakening of a giant?

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Cryptococcal meningitis in non-HIV-infected patients

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Susceptibility to antifungal agents among Cryptococcus neoformans varieties isolated from patients at a university hospital

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the [...]

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods.

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Molecular epidemiology of clinical Cryptococcus neoformans strains from India

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998.

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance Group

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Current scenario of cryptococcosis and antifungal susceptibility pattern in India: a cause for reappraisal

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

Comparative analysis of Etest and broth microdilution method (AFST-EUCAST) for trends in antifungal drug susceptibility testing of Brazilian Cryptococcus neoformans isolates.

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy

1 reference

https://api.crossref.org/works/10.1007%2FS11046-012-9528-9

21 January 2018

In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22354778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure

1 reference

https://pubmed.ncbi.nlm.nih.gov/22354778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/22354778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variation in electrophoretic karyotype and antifungal susceptibility of clinical isolates of Cryptococcus neoformans at a university-affiliated teaching hospital from 1987 to 1994.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22354778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22354778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans

1 reference

https://pubmed.ncbi.nlm.nih.gov/22354778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22354778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of broth macrodilution, broth microdilution and E-test susceptibility tests of Cryptococcus neoformans for fluconazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/22354778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22354778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence of initial infection in recurrent Cryptococcus neoformans meningitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22354778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans

1 reference

https://pubmed.ncbi.nlm.nih.gov/22354778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose

1 reference

https://pubmed.ncbi.nlm.nih.gov/22354778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22354778

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11046-012-9528-9

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22354778

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22354778

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50962922&oldid=1950887209"